124
Participants
Start Date
March 17, 2021
Primary Completion Date
August 16, 2023
Study Completion Date
February 9, 2024
BMS-986263
Specified dose on specified days
Placebo
Specified dose on specified days
Azienda Ospedaliera Universitaria Di Messina G. Martino-D.A.I. Medicina Interna, Messina
Local Institution, Rome
Local Institution - 0004, Taoyuan District
Local Institution - 0001, Kaohsiung City
Local Institution - 0089, Ciudad de Buenos Aires
Local Institution - 0209, Quilmes
Local Institution - 0126, San Juan Bautista
Local Institution - 0009, Edegem
Local Institution - 0133, Leuven
Local Institution - 0074, Bern
Local Institution - 0102, Lugano
Local Institution - 0006, Ghent
Local Institution, Taipei
NYU Langone Health-Department of Medicine, New York
Local Institution, New York
Local Institution, Taipei
Local Institution - 0091, Berlin
Research Foundation of SUNY - University of Buffalo, Buffalo
Local Institution - 0177, Philadelphia
Local Institution - 0017, Philadelphia
Local Institution - 0150, Baltimore
Local Institution - 0093, Incheon
Local Institution - 0194, Lübeck
Local Institution - 0073, Kiel
Local Institution - 0080, Madrid
Local Institution - 0039, Madrid
Local Institution - 0038, Madrid
Local Institution - 0206, Morehead City
Local Institution - 0036, Málaga
Local Institution - 0096, Hanover
Local Institution - 0025, Winter Park
Local Institution - 0061, Miami
Florida Research Institute, Lakewood Rch
Local Institution - 0024, Leesburg
University Diabetes & Endocrine Consultants, Chattanooga
Local Institution - 0037, Santander
Local Institution - 0054, Bologna
Local Institution - 0041, Seville
Local Institution - 0099, Essen
Local Institution - 0035, Valencia
Local Institution - 0043, Valencia
Local Institution - 0121, Iowa City
Local Institution - 0204, Trier
Local Institution - 0029, Vandœuvre-lès-Nancy
Local Institution - 0071, Mainz
Local Institution - 0051, Pisa
Local Institution - 0082, Frankfurt am Main
Local Institution - 0077, Kansas City
Local Institution - 0137, Strasbourg
Local Institution - 0186, Omaha
Local Institution - 0094, Lyon
Local Institution - 0101, Paris
Local Institution - 0105, Paris
Local Institution - 0171, Dallas
Local Institution - 0109, Houston
Local Institution - 0013, San Antonio
Local Institution, McAllen
Local Institution - 0060, Munich
Local Institution, Phoenix
Arizona Clinical Trials - Tucson, Chandler
Local Institution - 0173, Chandler
The Institute for Liver Health-The Institute for Liver Health, Chandler
GastroIntestinal BioSciences, Los Angeles
Local Institution - 0115, Palermo
Local Institution - 0140, La Jolla
Local Institution - 0205, Lancaster
Local Institution - 0202, Créteil
Local Institution - 0143, Redwood City
Local Institution - 0056, Haifa
Local Institution - 0076, Petah Tikva
Local Institution - 0193, Gifu
Local Institution - 0058, Ramat Gan
Local Institution - 0057, Tel Aviv
Local Institution - 0026, Hiroshima
Local Institution - 0135, Kagoshima
Local Institution, Ribeirão Preto
Local Institution, Porto Alegre
Local Institution - 0122, Richmond
Local Institution, Fall River
Local Institution - 0059, Buenos Aires
Local Institution - 0083, Salvador
Local Institution - 0182, Bento Gonçalves
Local Institution - 0187, Barretos
Local Institution - 0188, Botucatu
Local Institution - 0196, São Bernardo do Campo
Local Institution - 0120, São Paulo
Local Institution, São Paulo
Local Institution - 0128, Victoria
Local Institution - 0097, Toronto
Local Institution - 0031, Nice
Local Institution - 0200, Tōon
Local Institution - 0048, Kurume
Local Institution - 0049, Sapporo
Local Institution - 0127, Shiwagun Yahabatyo
Local Institution - 0075, Yokohama
Local Institution - 0155, Matsumoto
Local Institution - 0111, Kashihara
Local Institution - 0163, Sakai
Local Institution - 0125, Bunkyō
Local Institution - 0138, Minato-ku
Local Institution - 0199, Aomori
Local Institution - 0131, Kyoto
Local Institution - 0132, Yamagata
Local Institution - 0012, San Juan
Local Institution - 0066, Seodaemun-gu
Local Institution - 0090, Seoul
Local Institution - 0040, Barcelona
Local Institution - 0011, Nottingham
Local Institution - 0034, Hull
Local Institution - 0124, Liverpool
Local Institution - 0005, London
Local Institution, Southampton
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY